Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04018976 · ClinicalTrials.gov registry record · NA
AVACEN Treatment Method and Postprandial Blood Glucose
A NA study of Postprandial Hyperglycemia, sponsored by San Diego State University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT04018976: Completed NA study of Postprandial Hyperglycemia, sponsored by San Diego State University.
NCT04018976 is a NA study of Postprandial Hyperglycemia that has completed, run by San Diego State University. The registered enrollment target is 13 participants, below the 22-participant average among 4 other Postprandial Hyperglycemia trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04018976, a NA study of Postprandial Hyperglycemia, has completed, sponsored by San Diego State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
A double-blind crossover randomized controlled trial to investigate the effects of the AVACEN device on postprandial blood glucose. The AVACEN device creates negative pressure around the hand while heating the palm. Two sham devices, one providing heat but no vacuum and one providing neither heat nor vacuum were also used. Each subject will use each of these three devices during the first hour of a 2-hour oral glucose tolerance test on separate visits. Subjects arrived in the morning following an overnight fast. Fasting blood glucose, blood pressure, tympanic temperature, and subjective thermal ratings were measured before and throughout the 2-hour oral glucose tolerance test.
Primary Outcome
Measuring peak postprandial blood glucose with Contour Next glucometer
Conditions Studied
Interventions
- DEVICE AVACEN 100
- DEVICE AVACEN 100 heat only
- DEVICE AVACEN 100 sham
Study Locations (1)
California
- Jeff Moore - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-05-05 |
| Est. Completion | 2019-09-15 |
| Phase | NA |
What the finished NCT04018976 record still lists
NCT04018976 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 22-participant average among 4 other Postprandial Hyperglycemia trials with a reported enrollment target (41% lower).
The record links to 1 condition, with Postprandial Hyperglycemia appearing as the primary indexed condition, and to 3 interventions - of which AVACEN 100 is the first listed.
NCT04018976 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04018976 about?
NCT04018976 is a clinical study titled "AVACEN Treatment Method and Postprandial Blood Glucose". A double-blind crossover randomized controlled trial to investigate the effects of the AVACEN device on postprandial blood glucose. The AVACEN device creates negative pressure around the hand while heating the palm. Two sham devices, one providing heat but no vacuum and one providing neither heat no...
What is the current status of trial NCT04018976?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2019-05-05. Estimated completion is 2019-09-15.
What conditions does trial NCT04018976 study?
This clinical trial studies the following conditions: Postprandial Hyperglycemia.
What interventions are being tested in trial NCT04018976?
The interventions under investigation include: AVACEN 100 (DEVICE), AVACEN 100 heat only (DEVICE), AVACEN 100 sham (DEVICE).
Who is sponsoring clinical trial NCT04018976?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04018976 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postprandial Hyperglycemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cardiometabolic Benefits of Potatoes Mediated Along the Gut-Vessel Axis in Adults With Metabolic Syndrome
COMPLETED · NA
-
Evaluating the Acute Glycemic Response to Different Strategies of Breaking Up Sedentary Time
COMPLETED · NA
-
The Attenuating Effect of Soluble Fiber Consumption on Postprandial Glycemia in Humans
COMPLETED · NA
-
Glycemic Response of Whole Beans and Bean Products
COMPLETED · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI